BSH 2017 lymphoma highlights: looking at synergies between immuno-oncology agents

Graham Collins, MA, MBBS, MRCP, FRCPath, DPhil of Oxford University Hospitals NHS Foundation Trust, Oxford, UK discusses his highlights from the Free Lymphoma/CLL Communications session held at the 2017 British Society for Haematology (BSH) Annual Scientific Meeting in Brighton, UK. Dr Collins highlights a presentation on preclinical research looking at potential synergies between immune-oncology agents; it showed the potential for a combination between anti-CD20 and anti-CD27 antibodies in lymphoma.

Share this video